1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Celyad Oncology SA
  6. News
  7. Summary
    CYAD   BE0974260896

CELYAD ONCOLOGY SA

(CYAD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CELYAD ONCOLOGY SA
05/17Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
AQ
05/06Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/05CELYAD ONCOLOGY SA : 1st quarter results
CO
05/05CELYAD ONCOLOGY SA : Proxy Statments
CO
04/01CELYAD ONCOLOGY SA : Ordinary general shareholder meeting
CO
03/25TRANSCRIPT : Celyad Oncology SA, 2021 Earnings Call, Mar 25, 2022
CI
03/25CELYAD ONCOLOGY : Reports Full Year 2021 Financial Results and Recent Business Highlights ..
PU
03/25CELYAD ONCOLOGY : Letter to Shareholders – March 2022
PU
03/24Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/24Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
AQ
03/24CELYAD ONCOLOGY SA : Annual results
CO
03/24CELYAD ONCOLOGY SA : Mixed general shareholder meeting
CO
03/24CELYAD ONCOLOGY SA : SEC Filing 20 F
CO
03/17CELYAD ONCOLOGY : to Announce Full Year 2021 Financial Results and Host Conference Call
PU
03/02Celyad Says FDA Places Early-Stage Colorectal Cancer Trial on Clinical Hold
MT
More most relevant news
All news about CELYAD ONCOLOGY SA
05/17Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
AQ
05/06Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/05CELYAD ONCOLOGY SA : 1st quarter results
CO
05/05CELYAD ONCOLOGY SA : Proxy Statments
CO
04/01CELYAD ONCOLOGY SA : Ordinary general shareholder meeting
CO
03/25TRANSCRIPT : Celyad Oncology SA, 2021 Earnings Call, Mar 25, 2022
CI
03/25CELYAD ONCOLOGY : Reports Full Year 2021 Financial Results and Recent Business Highlights ..
PU
03/25CELYAD ONCOLOGY : Letter to Shareholders – March 2022
PU
03/24Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/24Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
AQ
More news
News in other languages on CELYAD ONCOLOGY SA
05/06Celyad Oncology SA annonce ses résultats pour le premier trimestre clos le 31 mars 2022
05/06Uitdagend kwartaal voor Celyad
03/25Verlies Celyad loopt op
03/24Celyad Oncology SA annonce ses résultats pour l'année complète se terminant le 31 décem..
03/16Brussel flink in het groen
03/16Bel20 weer boven 4.000 punten
03/02CELYAD : la suspension de l'essai de phase 1b confirmée
03/02Celyad Oncology chute de 6 % en raison de la suspension par la FDA de l'essai clinique ..
03/02Amerikaanse FDA schort studie Celyad op
03/02Celyad Oncology annonce l'arrêt clinique de l'essai de phase 1b CYAD-101-002
More news
Analyst Recommendations on CELYAD ONCOLOGY SA
02/28HC Wainwright Downgrades Celyad Oncology Neutral From Buy, Shares Plunge 12% at Midday ..
MT
01/11Wells Fargo Adjusts Celyad Oncology's Price Target to $11 from $20, Keeps Overweight Ra..
MT
2021CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $15 From $17, Ma..
MT
2021CELYAD ONCOLOGY : JonesTrading Downgrades Celyad Oncology to Hold from Buy
MT
2020CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $18 From $22, Ke..
MT
More recommendations
Press releases
05/17Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
AQ
03/25CELYAD ONCOLOGY : Reports Full Year 2021 Financial Results and Recent Business Highlights ..
PU
03/25CELYAD ONCOLOGY : Letter to Shareholders – March 2022
PU
03/24Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
AQ
03/17CELYAD ONCOLOGY : to Announce Full Year 2021 Financial Results and Host Conference Call
PU
More press releases
Upcoming event on CELYAD ONCOLOGY SA